-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Bellerophon Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2016 to 2022.
- Bellerophon Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 12.2M shares, a 28.2% increase year-over-year.
- Bellerophon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 9.55M shares, a 0.51% increase from 2021.
- Bellerophon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 9.5M shares, a 21.9% increase from 2020.
- Bellerophon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 7.8M shares, a 73.1% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)